| p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis D Bergamaschi, M Gasco, L Hiller, A Sullivan, N Syed, G Trigiante, I Yulug, ... Cancer cell 3 (4), 387-402, 2003 | 562 | 2003 |
| Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study M Muscaritoli, S Lucia, A Farcomeni, V Lorusso, V Saracino, C Barone, ... Oncotarget 8 (45), 79884, 2017 | 471 | 2017 |
| Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy M Merlano, V Vitale, R Rosso, M Benasso, R Corvò, M Cavallari, ... New England Journal of Medicine 327 (16), 1115-1121, 1992 | 361 | 1992 |
| Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the … M Merlano, M Benasso, R Corvò, R Rosso, V Vitale, F Blengio, G Numico, ... JNCI: Journal of the National Cancer Institute 88 (9), 583-589, 1996 | 324 | 1996 |
| NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives CL Nigro, M Macagno, D Sangiolo, L Bertolaccini, M Aglietta, MC Merlano Annals of translational medicine 7 (5), 2019 | 276 | 2019 |
| Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine G Numico, O Garrone, V Dongiovanni, N Silvestris, I Colantonio, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 255 | 2005 |
| Head and neck cancer: improving outcomes with a multidisciplinary approach C Lo Nigro, N Denaro, A Merlotti, M Merlano Cancer management and research, 363-371, 2017 | 252 | 2017 |
| Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial G Masi, L Salvatore, L Boni, F Loupakis, C Cremolini, L Fornaro, ... Annals of Oncology 26 (4), 724-730, 2015 | 208 | 2015 |
| Cancer of the larynx L Licitra, J Bernier, C Grandi, L Locati, M Merlano, G Gatta, JL Lefebvre Critical reviews in oncology/hematology 47 (1), 65-80, 2003 | 206 | 2003 |
| Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide M Feola, O Garrone, M Occelli, A Francini, A Biggi, G Visconti, F Albrile, ... International journal of cardiology 148 (2), 194-198, 2011 | 201 | 2011 |
| Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune … RL Ferris, HJ Lenz, AM Trotta, J García-Foncillas, J Schulten, F Audhuy, ... Cancer treatment reviews 63, 48-60, 2018 | 186 | 2018 |
| Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled … R Mesía, M Henke, A Fortin, H Minn, ACY Ancona, A Cmelak, ... The Lancet Oncology 16 (2), 208-220, 2015 | 183 | 2015 |
| Dysphagia in head and neck cancer patients: pretreatment evaluation, predictive factors, and assessment during radio-chemotherapy, recommendations N Denaro, MC Merlano, EG Russi Clinical and experimental otorhinolaryngology 6 (3), 117, 2013 | 183 | 2013 |
| Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation … EG Russi, R Corvò, A Merlotti, D Alterio, P Franco, S Pergolizzi, ... Cancer treatment reviews 38 (8), 1033-1049, 2012 | 173 | 2012 |
| Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: literature review and consensus A Schindler, N Denaro, EG Russi, N Pizzorni, P Bossi, A Merlotti, ... Critical reviews in oncology/hematology 96 (2), 372-384, 2015 | 164 | 2015 |
| Follow-up in head and neck cancer: do more does it mean do better? A systematic review and our proposal based on our experience N Denaro, MC Merlano, EG Russi Clinical and experimental otorhinolaryngology 9 (4), 287-297, 2016 | 156 | 2016 |
| Long noncoding RNA s as regulators of cancer immunity N Denaro, MC Merlano, C Lo Nigro Molecular oncology 13 (1), 61-73, 2019 | 154 | 2019 |
| Epigenetic inactivation of 14-3-3 σ in oral carcinoma: association with p16INK4a silencing and human papillomavirus negativity M Gasco, AK Bell, V Heath, A Sullivan, P Smith, L Hiller, I Yulug, ... Cancer research 62 (7), 2072-2076, 2002 | 151 | 2002 |
| Metastatic disease in head & neck oncology P Pisani, M Airoldi, A Allais, PA Valletti, M Battista, M Benazzo, R Briatore, ... Acta Otorhinolaryngologica Italica 40 (Suppl 1), S1, 2020 | 147 | 2020 |
| Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy C Pinto, CA Barone, G Girolomoni, EG Russi, MC Merlano, D Ferrari, ... The oncologist 16 (2), 228-238, 2011 | 147 | 2011 |
Nerina DenaroFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di MilanoAdresse e-mail validée de policlinico.mi.it
